Evidence map›Paper›PMID 33426780›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2021

Validation of a Bioassay for Predicting Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis.

Ching-Huang Ho, Andrea A Silva, Jon T Giles, Joan M Bathon, Daniel H Solomon, Katherine P Liao, I-Cheng Ho

Open access · greenAbstract readValidation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ching-Huang HoBrigham and Women's Hospital, Harvard Medical School, Boston, MA.
Andrea A SilvaBrigham and Women's Hospital, Harvard Medical School, Boston, MA.
Jon T GilesColumbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York, New York.
Joan M BathonColumbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York, New York.
Daniel H SolomonBrigham and Women's Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0001-8202-5428
Katherine P LiaoBrigham and Women's Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0002-4797-3200
I-Cheng HoBrigham and Women's Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0003-3906-0345
Brigham and Women's Hospital · USNewYork–Presbyterian Hospital · US

Funding

Treatments Against RA and Effect on FDG PET CT: The TARGET TRIALU01AR068043 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI BATHON, JOAN MARIE, SOLOMON, DANIEL HAL · 2015 to 2021
$8.7M
Causes and Roles of Hypercitrullination in Preclinical Rheumatoid ArthritisR01AR070171 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI HO, I-CHENG · 2017 to 2021
$2.1M
Utilizing the RA signature to predict TNFi responseR21AR074788 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI HO, I-CHENG · 2018 to 2019
$630k
NIAMS NIH HHS R01 AR070171NIAMS NIH HHS R21 AR074788NIAMS NIH HHS U01 AR068043
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdalimumabAgedArthritis, RheumatoidBiological AssayEtanerceptHumansMiddle AgedPrognosisProtein Tyrosine Phosphatase, Non-Receptor Type 22Reproducibility of ResultsTranscriptomeTreatment OutcomeTumor Necrosis Factor InhibitorsAdalimumabEtanerceptProtein Tyrosine Phosphatase, Non-Receptor Type 22PTPN22 protein, humanTumor Necrosis Factor Inhibitors

Identifiers

PMID33426780
PMCPMC8169520
OpenAlexW3119686443

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.